We propose a method to engineer the genome of bacteriophages to increase their effectiveness as antibacterial agents. Specifically, we exploit the redundancy of the triplet code to design genomes that avoid restriction sites while producing the same proteins as wild-type phages. We give an efficient algorithm to minimize the number of restriction sites against sets of cutter sequences, and demonstrate that that phage genomes can be significantly protected against surprisingly large sets of enzymes with no loss of function. Finally, we develop a model to explain why evolution has failed to eliminate many possible restriction sites despite selective pressure, thus motivating the need for genome-level sequence engineering. Contact:
INTRODUCTION
Bacteriophages are viruses which inject their own DNA into a host bacterium. The phage then takes over the genetic machinery of the cell to produce more phages, eventually killing the bacterium in the process. For this reason, bacteriophages have long been proposed as an antibacterial agent. Indeed, phages have been widely used in the former Soviet Union to fighting infections since the 1930's (Osborne, 2000) .
There is increasing interest in medical applications of bacteriophages, motivated by the growing problem of antibiotic resistance. Although promising, several hurdles must be overcome before bacteriophages can successfully compete with antibiotics as antibacterial agents. First, phages tend to be narrowly targeted, i.e. a particular phage can only successfully invade a narrow range of host cell types. Second, mammalian circulatory systems are adept at removing phages from the blood stream. Third, crude phage lysates often contain toxins to the host organism. However, recent work towards isolating long-circulating bacteriophages (Merril et al., 1996) shows considerable promise in overcoming these hurdles.
We propose a complementary approach to building better phages, by engineering them to avoid a primary bacterial defense mechanism. Restriction enzymes cut unmethylated DNA at specific patterns, or cutter sequences. Such enzymes, isolated from bacteria, have become a fundamental tool in manipulating DNA in the laboratory (Lander, 1989; Maniatis et al., 1982) . However, their primary biological role is as a bacterial defense mechanism against phages. Bacteria race to deploy restriction enzymes so as to cut the injected phage DNA into fragments before it can become biologically active. The greater the number of restriction sites, or occurrences of the given cutter sequence on the phage genome, the more vulnerable they are to the given restriction enzyme. A convincing body of evidence including Gelfand & Koonin (1997) ; Karlin et al. (1992 Karlin et al. ( , 1997 ; Sharp (1986) shows that natural selection has worked to reduce the number of restriction sites in phage genomes.
We propose further increasing the effectiveness of a given therapeutic phage by altering its genome to minimize the number of restriction sites for a given set of cutter sequences. One must be careful not to change the phenotype of the resulting phage, however. We propose to exploit the known redundancy in triplet code by which the 4 3 = 64 different codons (sequences of three consecutive nucleotide bases) in DNA either terminate transcription or map to one of the 20 different amino acids (or residues) which build up proteins. We seek the coding sequence which minimizes the number of restriction sites while still coding for the desired protein.
Paradoxically, it is the non-coding regions (often called 'junk DNA') which conservatively should be preserved verbatim from the wild-type encoding. Although these non-coding regions are less well understood, they contain most of the critical binding sites for regulatory elements and have other, still unknown, functions. Therefore, our program leaves these intergenic regions intact. In fact, the intergenic regions of bacteriophages are typically very short, a tribute to the evolutionary advantage of minimizing genome length in phages.
Our computational results are very encouraging -we demonstrate that there is sufficient flexibility in the genetic code to remove the overwhelming majority of restriction sites from genes, even when subjecting the phage to a battery of several dozen enzymes. Indeed, it is feasible to significantly protect any phage against the cutter sequences of all known restriction enzymes. Although there is a particular suite of cutter sequences specific to each bacterial host, such an approach eliminates the need to carefully assay the enzymes specific to a specific bacterium, and may increase the range of possible hosts for a given phage. Indeed, the IncPα plasmids are remarkable both for their broad host range and small number of restriction sites (Wilkins et al., 1996) . The laboratory technology needed to alter the genome of a phage to specification is available, and would clearly be worth employing if it could substantially improve the performance of a therapeutic agent. We are now pursuing laboratory implementation of these ideas.
Our paper is organized as follows. First, we present additional biological background on restriction enzymes, phages, and the triplet code. We then formalize our problem of minimizing restriction sites, and present an efficient dynamic programming algorithm to solve it for constant-length cutter sequences, as occur in nature. We prove the hardness of the problem as the length of the cutter-sequences increases, justifying our algorithmic approach. We then perform a series of experiments on a variety of phages and enzyme sets, which support our claims that a large fraction of restriction sites can be effectively removed without changing the phenotype of a phage. Finally, we propose a simple evolutionary model which explains why our technique can hope to generate more robust phages than the product of billions of years of natural selection.
RESTRICTION ENZYMES, PHAGES, AND THE GENETIC CODE

Restriction Enzymes
Restriction enzymes recognize and cut DNA molecules at particular patterns. For example, the enzyme EcoRI cuts at the pattern GAATTC. Enzymes are indigenous to specific bacteria, with the name of each enzyme denoting the order of discovery within the host organism (e.g. EcoRI was the first restriction enzyme discovered in E. Coli). The first restriction enzyme was discovered by Hamilton Smith in 1970. Restriction enzymes cut doublestranded DNA, and are classified as either type I or type II depending whether they cleave the strand at specific locations, with those that do (type II) significantly more important for biotechnology. Enzymes can be further classified according to whether they leave behind blunt or sticky ends, i.e. double-or single-stranded end fragments. Nathans & Smith (1975) and Lander (1989) provide early surveys on restriction enzymes.
The problem of constructing restriction maps, i.e. identifying all the locations of restriction sites on a genome, was a critical component to early sequencing projects. For example, Maniatis et al. (1982) provides a list of all restriction sites for the plasmid pBR322 under 81 different enzymes. Many interesting combinatorial and algorithmic problems have arisen in the context of technologies for restriction mapping, e.g. Goldstein & Waterman (1987) ; Newberg & Naor (1993) ; Skiena & Sundaram (1994) ; Stefik (1978) .
Rebase (Roberts, 2001 ) maintains a complete list of all known restriction enzymes, including cutter sequences, literature references, and commercial availability. As of January 1, 2001, 3487 different enzymes were known, defining at least 255 distinct cutter sequences. Cutter sequence lengths range in length from 2 to 15 bases. Although most enzymes cut at specific oligonucleotide base patterns, other enzymes recognize multiple sequences by allowing variants at specific base positions. For example, the cutter AACNNNNNNGTGC matches from the 5' to 3' end any sequence starting AAC, ending GTGC where they are separated any sequence of exactly six bases.
Bacteriophages
Bacteriophages were among the first organisms whose genomes were completely sequenced (Waterman, 1989) , a tribute both to their importance and their short genome lengths. Bacteriophages can breed rapidly, multiplying to several hundred daughter phages in about 20 minutes (Watson et al., 1992) . Bacteriophage genomes can be either linear or circular. Table 1 displays the characteristics the bacteriophages employed in our study. They vary substantially in length (from 3,569 to 48,502 base pairs) and gene content (from 4 to 102 genes). Almost all of them have very little non-coding DNA -none of the phages in Table 1 have more than 40% non-coding DNA, with many phages below 10%.
There is abundant evidence that both phage genomes and bacterial hosts evolve to avoid restriction enzyme cut sites. Sharp (1986) established a smaller than expected number of restriction sites in phage genomes and attributed this to natural selection. A second study of five bacteriophage genomes (Karlin et al., 1992) shows four of them significantly depleted in the short palindromic sequences typically associated with restriction sites. Further the T4 phage, the lone exception to this pattern, derives protection from the modification of cytosine to hydroxymethylcytosine. Table 1 also provides measures of the number of short palindromes in the coding and non-coding regions of each phage, as well as the expected number of such palindromes by averaging 10 random permutations of the genome. Comparing the actual and expected counts for palindromic subsequences in Table 1 shows that 4-and 6-length palindromes are substantially depleted in almost all of our phages. The greater depletion of 6-palindromes presumably reflects the greater likelihood for a random mutation to disrupt the site. There is no clear pattern as to whether depletion occurs more or less frequently inside coding regions.
There has been a succession of statistical results of the distribution of patterns in DNA sequences, reflecting the increasing body of available sequence data (Karlin et al., 1992 (Karlin et al., , 1997 Panina et al., 2000) . Indeed, Gelfand & Koonin (1997) have established that bacterial genomes avoid cut sites associated with their own type II restriction enzymes. This depletion helps protect the bacteria against the occasional failure of methylation systems. Patterns corresponding to enzymes in other bacterial species also tend to be depleted, suggesting the lateral transfer of restriction-modification systems across species.
The Triplet Code
Because there are more codons (64) than residues (20 plus the stop symbol), there is inherent redundancy in the triplet code for proteins. Certain residues (e.g. methionine) have only a single corresponding codon, while other residues (e.g. arginine) have as many as 6 corresponding codons. This freedom implies that the number of possible DNA sequences coding for a given protein grows exponentially in the length of the protein. For example, Cohen & Skiena (2000) show that a modest-size plant hemoglobin of 147 residues (accession number AB010831) may be coded for by 1.7×10 75 distinct DNA sequences. We seek the coding which minimizes the total number of restriction sites for a given set of enzyme cutter sequences.
We note that codon usage patterns vary significantly among organisms, and efficient translation requires conforming to these distributions. Thus, removing potential restriction sites leads to improved fitness in one respect (lower probability of DNA degradation), but at a possible decrease in fitness in another (less efficient translation). Our goal here is to demonstrate the potential win in designing a "super-phage". Our methods can be generalized to significantly respect codon distributions, with what we expect will be little degradation in performance.
We have previously employed dynamic programming methods to exploit the redundancy of the genetic code. Cohen & Skiena (2000) investigate the degree to which alternate encodings of a given protein can effect the strength of the RNA secondary structure. An interesting connection between these problems is that rRNA genes are typically in the regions least depleted of palindromes in bacterial genomes, perhaps reflecting the tradeoff between the secondary structure necessary for RNA function and the tendency for restriction enzymes to nick such structures (Mizuuchi et al., 1982) .
MINIMIZING RESTRICTION SITES
The previous discussion motivates the following minimum restriction site genome problem:
Input: The DNA sequence S of a given phage P, a set of genes G = {g 1 , . . . , g k } each defined by an interval on S, a set of restriction enzymes E = {e 1 , . . . , e m }, where each enzyme is associated with a given cutter sequence, and an integer x. Output: A DNA sequence S where |S| = |S |, such that for each gene g i ∈ G the corresponding interval in S and S code for identical proteins, all non-coding regions of S are conserved in S , and the number of restrictions sites in S over all enzymes in E is at most x.
We propose the following dynamic programming algorithm for the minimum restriction site genome problem. Let M [i, W ] be the minimum number of enzyme cuts possible to encode the first i bases of S, where the last l bases of S are defined by the string W = w 1 w 2 . . . w l . Then: 
Proof:
The correctness of the recurrence relation follows provided the state window length l is at least as long as the longest cutter in the enzyme set. Each cut site is counted exactly once, since cut (W ) only counts suffix cuts, and all possible windows are optimized over.
A naive time analysis would be O(nml4 l ) time, since at each sequence position 4 l windows must be considered, and at each window (1) the legality of the window must be established for all m genes and (2) the number of suffix cuts for each enzyme established. In fact, there can only be at most 3 × 6 l/3 = O(1.817 l ) distinct legal windows of length l at any single position, since the most heavily represented residue is assigned only six of the 64 possible codons.
The number of suffix cuts can be quickly identified using a suffix tree data structure (Gusfield, 1997) , over all legal windows at a position.
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There are a variety of real-world complications which must be considered in redesigning genomes to avoid restriction sites:
• Overlapping genes -It is fairly common for two or more genes to share a given region on a genome. Sometimes multiple overlapping genes all reside in the same frame and terminate on the same stop codon. These provide no additional constraints over the longest gene in the set, as all must code for the same amino acid sequence in the common region.
However, many phages also have overlapping genes residing in different reading frames. In such cases, we are restricted to generating encodings which respect the genes in all the reading frames containing a given position.
• Genes on alternate strands -All but seven of our test phages (specifically Chp1, G4, MS2, MX, N95, fs-2, and psi-M2) exhibited genes on both the upper and lower strands of the genome. Genes on both strands must be conserved. We are restricted to using encodings which respect all active reading frames covering a given position, with codings on the lower strand appropriately complemented.
The layers column in Table 1 records the maximum number of genes to cover some portion of the given genome. Multiplicities are due to overlapping gene and genes on alternate strands.
• Non-palindromic cutters -A substantial majority of cutters for restriction enzymes are palindromic, meaning that the cutter is equal to its reverse complement. For palindromic cutters, there is no cut on the bottom strand which is not matched with one on the upper strand, and hence the bottom strand can be disregarded from our computation. However, for non-palindromic enzymes, we must explicitly avoid the presence of the reverse complement of the cutter to avoid cutting the alternate strand.
Although the dynamic programming recurrence above is conceptually simple, an efficient implementation requires care. Our implementation maintain legal windows as packed bits in a long integer. All known cutters in Rebase are at most 15 bases long, and thus a 32 bit integer suffices to encode the window at 2 bits per symbol. We maintain a sparse dynamic program (since most possible windows are illegal) by using an array of hash tables, and use linear search (instead of suffix trees) to count enzyme cuts. Our implementation, which is 2000 lines of C, can run each of our phage/enzyme set pairs in a few minutes on a modest desktop workstation.
HARDNESS FOR LONG CUTTERS
Although our algorithm is efficient enough to easily handle all known restriction enzymes, it heavily depends upon the fact that each enzyme cutter sequence is short. In fact, THEOREM 2. The minimum restriction site genome problem is NP-complete for general enzyme lengths.
Proof:
We use a reduction from maximum satisfiability (MAX-SAT). In MAX-SAT, we are given a set of CNF clauses C = {c 1 , . . . , c k } defined over a set of boolean variables V = {v 1 , . . . , v n }.
We reduce this to the minimum restriction site genome problem. Suppose the wild-type genome S consists of n bases, each of which is allowed to be one of two possibilities (say either A or T but not C or G). Let the state of the i th base reflect the truth assignment of the i th variable. Each clause will be satisfied unless the relevant bases are exactly set so the appropriate literals are negated. For each clause, we will construct an enzyme of length n, with don't care 'N' bases at every position except the relevant bases for the clause, which will be set such that the enzyme will match iff the truth assignment does not satisfy the resulting clause. Thus the assignment which minimizes the number of matching enzymes maximizes the number of satisfied clauses, giving the reduction.
Hardness of approximation follows from the fact that maximum satisfiability is APX-complete (Papadimitriou & Yannakakis, 1991) .
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It would be interesting to resolve the complexity of the problem for small numbers of enzymes.
EXPERIMENTAL RESULTS
To test the effectiveness of our algorithm, and measure the extent to which the triple code allows us to remove restriction sites, we optimized each of the phage genomes of Table 1 against a variety of enzyme cutter subsets, described in Table 2 . This enzyme subsets can be partitioned into three general classes:
• All cutter sequences -These sets consist of all known sequences of particular length. In all sets, cutter sequences of length greater than eight have been ignored. In particular, we consider the set of all simple cutters (ALL-SIMPLE), all cutters including ambiguous bases (NON-SIMPLE), and all simple cutters of length 4, 6, and 8 (ALL-SIMPLE-4, -6, and -8).
• Dense organism-specific sequences -Different suites of enzymes constitute different bacteria defense mechanisms. These sets constitute the host-specific sets of enzymes for the six genus with the largest known enzyme sets, ranging in size from 49 to 26 distinct cutters each. These are Pseudomonas, Escherichia, Streptomyces, Helicobacter, Neisseria, and Thermus.
• Sparser organism-specific sequences -Here we consider the host-specific enzyme sets for the next five largest known enzyme sets, ranging in size from 11 The cut sequences associated with the enzyme subsets in Table 2 have been distinguished into those which are self-palindromic (i.e. are identical to their reverse complement), and those which are instead irregular. The expected cuts field of Table 2 gives the expected number of cuts per site a random sequence with equiprobable bases would endure if exposed to the given set of enzymes. Larger number of irregular enzymes with shorter cut sequences increases the expected number of cuts.
Our optimization results are described in Tables 3 and 4 , grouped according to enzyme class. The results for sparse organism-specific sequences have been omitted because of lack of space. The results for fixed length cutters are very encouraging, demonstrating that we have the freedom to remove every instance of every 8-cutter from the coding regions of every phage we considered. We are able to remove almost 98% of all 6-cutter sites or almost 94% of all 4-cutter sites. A few phages, particularly G4 and SPP1, prove unusually resistant to optimization, leaving between 10% and 20% of all sites. Combining all simple cutters begins to overwhelm our ability to remove sites, but even here we typically remove 80% or more of the original sites. There seems to be no significant difference in our ability to remove simple or ambiguous cutter sequences. Table 4 documents our success at removing organismspecific sets of sites. It is interesting to note that the expected site density of the different sets does not correspond directly to the number of distinct cutters. The Heliobacter set has more than twice as much expected site density as Pseudomonas, even though it has roughly half as many cutters (29 vs. 49). The secret is that Pseudomonas has longer cutters on average than Heliobacter. However, we are able to remove about 90% of all wild-type sites in most cases.
The primary factor affecting how successfully restriction sites can be removed from a given genome is a function of how densely the restriction sites are packed. This density is a function of both the number of enzymes, and the length of their cutting sequences more than a function of the sequence. We anticipate that there is sufficient freedom in the genetic code to remove essentially all sites if they occur with sufficiently low density.
To study the effect of site density on the performance of our algorithm, in Figure 3 we plot the wild-type site density versus the optimized site density for each enzyme set/phage pair. The resulting curve appears to be growing somewhat super-linearly. Certainly the heavy concentration on the x-axis suggests that we are likely to remove all sites if the density is low enough.
The spreading of the point cloud shows that expected site density is not a perfect predictor of the number of optimized sites, but that the variance grows as the density grows. This presumably reflects the fact that certain cutter sequence sets are more "interconnected" than others, meaning that pairs of complementary enzymes make it difficult to erase one site without adding another. It would be interesting to make a more detailed study of the cutter sequences associated with given organisms, to see if such complementary sets tend to be selected for.
ELIMINATING RESTRICTION SITES THROUGH EVOLUTION
Since eliminating restriction sites from phage genomes confers protection to a bacteriophage, it is reasonable to ask why billions of years of evolution hasn't already removed as many such sites as possible. Evolution in phages, like other viruses, can happen rapidly because of short generation times and the large number of phages that can be produced in each generation. Indeed, previous work in developing robust phages (Merril et al., 1996) has focused on using natural selection to isolate the longest-lived members of a phage population. In this section, we introduce a simple mathematical model which S259 Table 4 . Number of restriction sites cut in coding regions by enzyme sets in given bacteria for both wild-type and optimized phages.
which implies
If each restriction site almost always lethal, i.e. p cut ∼ 1, then natural selection would drive i eqi → n as suggested by the model. If restriction sites had no deleterious effect, i.e. p cut = 0, all 2 n strings are equally favored and we predict n/2 1's in the genome. We have seen that typical phage genomes can have dozens of restriction sites, hence p cut must be fairly low for any significant phage population to survive. Wilkins et al. (1996) established that between 1/10th to 1/100, 000th of bacteria survive a phage infection. Assuming a survival value of 1/1000 for a phage with ten restriction sites yields p cut ≈ 0.5, which places equilibrium at removing only 80% of all restriction sites. Similar calculations for a phage with 100 restriction sites yields p cut ≈ 0.06 and equilibrium at only 53% of all restriction sites.
Thus we conclude that eliminating a small number of restriction sites from a genome may have such a minor impact on viability that these mutations will not be significantly selected for. However, without these intermediate steps, global optimization cannot be achieved. Under such a model, a globally optimized phage may be exponentially more likely to survive, and hence significantly more valuable as a therapeutic agent.
